In a deal that Noetik’s leaders call a new paradigm for AI-focused biotech, GSK is paying millions to license AI models rather than drug candidates.
The British pharma giant is ...
Noetik, an AI-native biotech company pioneering self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced today a five-year strategic collaboration and AI model licensing agreement ...
Biology voices weigh in on the impact of AI on drug discovery from the largest NeurIPS research conference to date.
More than 24,000 machine learning experts gathered for the largest ...
